Blackley Seth 4
4 · Evolent Health, Inc. · Filed Jul 6, 2026
Research Summary
AI-generated summary of this filing
Evolent Health (EVH) CEO Seth Blackley Receives Award
What Happened
Seth Blackley, CEO of Evolent Health (EVH), was granted 446,102 restricted stock units (RSUs) on July 1, 2026 (reported on a Form 4 filed July 6, 2026). The RSUs were reported at $0.00 per share (standard for awards). To satisfy tax withholding upon the grant/vesting mechanics, 10,297 shares were withheld/disposed at $5.74 per share, totaling approximately $59,105.
Key Details
- Transaction date: July 1, 2026; Form 4 filed July 6, 2026 (appears to be filed after the typical two-business-day deadline).
- Grant: 446,102 RSUs reported as Award (code A) at $0.00 per share.
- Tax withholding: 10,297 shares disposed (code F) at $5.74/share = $59,105 withheld to cover taxes.
- Shares owned after transaction: Not disclosed on this Form 4.
- Notable footnotes:
- Award is under the Amended and Restated 2015 Omnibus Incentive Compensation Plan.
- This grant is a second portion of the annual award (first portion granted March 2, 2026); additional shares were approved by shareholders on June 4, 2026.
- Vesting schedule: 34% on July 1, 2027; 33% on July 1, 2028; 33% on July 1, 2029.
- F4 indicates these RSUs include units from awards previously reported. F5 explains the withheld shares were to satisfy tax withholding.
Context
This was an equity award (RSUs) to the CEO, not an open-market purchase or sale of existing shares. RSU grants are common executive compensation and do not by themselves indicate a buy or sell signal; the tax withholding (code F) is a routine disposition to cover taxes. The late filing may be noteworthy for compliance tracking but does not change the substance of the award.
Insider Transaction Report
- Award
Class A Common Stock
[F1][F2][F3][F4]2026-07-01+446,102→ 1,283,064 total - Tax Payment
Class A Common Stock
[F5][F4]2026-07-01$5.74/sh−10,297$59,105→ 1,272,767 total
Footnotes (5)
- [F1]Represents restricted stock units granted to Mr. Blackley pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle. The first portion of the award was granted on March 2, 2026, and this portion of the award was granted on July 1, 2026, following the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 4, 2026, at the Company's Annual Meeting.
- [F3]Securities vest at a rate of 34% on July 1, 2027, and 33% on July 1, 2028, and July 1, 2029.
- [F4]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F5]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.